The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
COL3A1haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy
Open accessAbstract
Purpose To characterize the clinical outcome of heterozygosity for COL3A1 null mutations in Ehlers-Danlos syndrome type IV, the vascular type.Methods We identified mutations that produced premature termination codons and resulted in nonsense-mediated messenger RNA decay in 19 families. We reviewed the clinical and family histories and medical complications in 54 individuals from these families with COL3A1 null mutations.Results Compared with individuals with missense or exon-skipping mutations, we found that life span was extended, the age of first complication was delayed by almost 15 years, and major complications were limited to vascular events. The families were ascertained after a complication in a single individual, but only 28% of relatives, some of whom had reached their seventies or eighties without incidents, had a complication and only 30% had minor clinical features of Ehlers-Danlos syndrome type IV CONCLUSION: Null mutations have reduced penetrance compared with missense and splicing mutations, and the phenotype seems to be limited almost entirely to vascular events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Splice site mutations that lead to exon skipping have the lowest median survival.”
In the citing paper
“the nature of the specific COL3A1 mutation influences life expectancy.”
In the citing paper
“Mutations leading to premature termination of translation and nonsense-mediated mRNA decay are rare (less than 5%).”
In the citing paper
“Substitutions of bulky residues (Arg, Asp, Glu, Val) for glycine residues in the triple helical domain are usually less severe than splice site mutations, but more consequential than substitutions by smaller residues (Ala, Ser, Cys).”
In the citing paper
“Heterozygosity for COL3A1 null alleles typically produces a milder clinical phenotype with a significant delayed onset of complications [4, 9–12].”
In the citing paper
“These null mutations cause half the normal amount of COLLIII to be secreted [11,12].”
In the citing paper
“Besides, the present patients exhibited a full-blown expression of the disease with several major arterial events, in line with the limited genotype-phenotype correlation that associates this type of structural mutations with a more severe clinical phenotype [4,9–12].”
Citations
Cites
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
Pepin, M., Schwarze, U., Superti-Furga, A., & Byers, P. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421001 · Cited by 1,344
Self-citationLiu, X., Wu, H., Byrne, M., Krane, S., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1852 · Cited by 614
The human type I collagen mutation database
Dalgleish, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.181 · Cited by 315
Schwarze, U., Schievink, W. I., Petty, E., Jaff, M. R., Babovic-Vuksanovic, D., Cherry, K. J., Pepin, M., & Byers, P. H. (2001) · The American Journal of Human Genetics · doi:10.1086/324123 · Cited by 184
Self-citationSchwarze, U., Goldstein, J. A., & Byers, P. H. (1997) · The American Journal of Human Genetics · doi:10.1086/301641 · Cited by 74
Self-citationSchwarze, U., Starman, B. J., & Byers, P. H. (1999) · The American Journal of Human Genetics · doi:10.1086/302512 · Cited by 64
Self-citationHomozygosity for a null allele of COL3A1 results in recessive Ehlers–Danlos syndrome
Plancke, A., Holder‐Espinasse, M., Rigau, V., Manouvrier‐Hanu, S., Claustres, M., & Kien, P. K. V. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.76 · Cited by 52
The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome
Cooper, T. K., Zhong, Q., Krawczyk, M., Tae, H.-J., Müller, G. A., Schubert, R., Myers, L. A., Dietz, H. C., Talan, M. I., & Briest, W. (2010) · Veterinary Pathology · doi:10.1177/0300985810374842 · Cited by 51
Khalique, Z., Lyons, O., Clough, R. E., Bell, R. E., REIDY, J. F., Schwarze, U., Byers, P. H., & Taylor, P. R. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.07.009 · Cited by 24
Self-citationEhlers-Danlos syndromes: Revised nosology, Villefranche, 1997
Beighton, P., Paepe, A. D., Steinmann, B., Tsipouras, P., & Wenstrup, R. J. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980428)77:1
Cited by
Sorted by citations
Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler‐Smith, C., & Kehrer‐Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 671
Lattouf, R., Younes, R., Lutomski, D., Naaman, N., Godeau, G., Senni, K., & Changotade, S. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414545787 · Cited by 524
The Ehlers–Danlos syndrome, a disorder with many faces
De Paepe, A., & Malfait, F. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01858.x · Cited by 379
Pepin, M. G., Schwarze, U., Rice, K. M., Liu, M., Leistritz, & Byers, P. H. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.72 · Cited by 313
Self-citationFrank, M., Albuisson, J., Ranque, B., Golmard, L., Mazzella, J.-M., Bal-Theoleyre, L., Fauret, A.-L., Mirault, T., Denarié, N., Mousseaux, E., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.32 · Cited by 248
Pregnancy-related deaths and complications in women with vascular Ehlers–Danlos syndrome
Murray, M. L., Pepin, M. G., Peterson, S., & Byers, P. H. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.53 · Cited by 183
Self-citationThe Genetics of Thoracic Aortic Aneurysms and Dissection: A Clinical Perspective
Ostberg, N. P., Zafar, M. A., Ziganshin, B. A., & Elefteriades, J. A. (2020) · Biomolecules · doi:10.3390/biom10020182 · Cited by 145
Arterial complications of vascular Ehlers-Danlos syndrome
Eagleton, M. J. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2016.06.120 · Cited by 133
Shalhub, S., Black, J. H., Cecchi, A. C., Zhi, X., Griswold, B. F., Safi, H. J., Milewicz, D. M., & McDonnell, N. B. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.01.070 · Cited by 132
Malfait, F., & Paepe, A. D. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7893-1_9 · Cited by 126
Mechanisms of Mendelian dominance
Veitia, R. A., Caburet, S., & Birchler, J. A. (2017) · Clinical Genetics · doi:10.1111/cge.13107 · Cited by 111
Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review
D’hondt, S., Damme, T. V., & Malfait, F. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.138 · Cited by 92
Causes and effects of haploinsufficiency
Johnson, A. F., Nguyen, H. T., & Veitia, R. A. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12527 · Cited by 90
Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome
Bowen, C. J., Calderón, J. F., Burger, Z., Rykiel, G., Davis, E. C., Helmers, M. R., Benke, K. S., MacFarlane, E. G., & Dietz, H. C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130730 · Cited by 81
Bradley, T. J., Bowdin, S. C., Morel, C. F., & Pyeritz, R. E. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.11.007 · Cited by 83
D'hondt, S., Guillemyn, B., Syx, D., Symoens, S., De Rycke, R., Vanhoutte, L., Toussaint, W., Lambrecht, B. N., De Paepe, A., Keene, D. R., et al. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.008 · Cited by 79
Campens, L., Callewaert, B. L., Mosquera, L. M., Renard, M., Symoens, S., Paepe, A. D., Coucke, P. J., & Backer, J. F. A. D. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0221-6 · Cited by 81
Shalhub, S., Byers, P. H., Hicks, K. L., Charlton-Ouw, K. M., Zarkowsky, D. S., Coleman, D. M., Davis, F. M., Regalado, E. S., Caridi, G. D., Weaver, K. N., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.01.069 · Cited by 81
Self-citationHeritable thoracic aortic disorders
Pyeritz, R. E. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000023 · Cited by 76
Pángalos, C., Hagnefelt, B., Λιλάκος, Κ., & Konialis, C. P. (2016) · PeerJ · doi:10.7717/peerj.1955 · Cited by 77
Ehlers–Danlos syndrome: A showcase of conditions that lead to understanding matrix biology
Byers, P. H., & Murray, M. L. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.07.005 · Cited by 68
“One striking example, however, is that heterozygosity for null mutations in COL3A1 results in an attenuated phenotype (Leistritz et al., 2011).”
BackgroundSelf-citationWallace, S. E., Regalado, E. S., Gong, L., Janda, A., Guo, D., Russo, C., Kulmacz, R. J., Hanna, N., Jondeau, G., Boileau, C., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0038-0 · Cited by 67
The Collagenopathies: Review of Clinical Phenotypes and Molecular Correlations
Jobling, R. K., D'Souza, R. D., Baker, N. L., Lara‐Corrales, I., Mendoza‐Londono, R., Dupuis, L., Savarirayan, R., Ala‐Kokko, L., & Kannus, P. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0394-3 · Cited by 69
Overwater, E., Marsili, L., Baars, M. J. H., Baas, A. F., van de Beek, I., Dulfer, E., van Hagen, J. M., Hilhorst‐Hofstee, Y., Kempers, M. J. E., Krapels, I. P. C., et al. (2018) · Human Mutation · doi:10.1002/humu.23565 · Cited by 61
Heritable Collagen Disorders: The Paradigm of the Ehlers—Danlos Syndrome
Byers, P. H., & Murray, M. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/skinbio.2012.3 · Cited by 57
Self-citationA multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis
Shalhub, S., Byers, P. H., Hicks, K. L., Coleman, D. M., Davis, F. M., Caridi, G. D., Weaver, K. N., Miller, E. M., Schermerhorn, M. L., Shean, K. E., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.04.487 · Cited by 56
Self-citationTransforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome
Morissette, R., Schoenhoff, F., Xu, Z., Shilane, D. A., Griswold, B. F., Chen, W., Yang, J., Zhu, J., Fert-Bober, J., Sloper, L., et al. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000280 · Cited by 51
Chiarelli, N., Carini, G., Zoppi, N., Ritelli, M., & Colombi, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191220 · Cited by 45
Jørgensen, A., Fagerheim, T., Rand‐Hendriksen, S., Lunde, P. I., Vorren, T., Pepin, M. G., Leistritz, D. F., & Byers, P. H. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.181 · Cited by 46
Self-citationFirst genetic analysis of aneurysm genes in familial and sporadic abdominal aortic aneurysm
van de Luijtgaarden, K. M., Heijsman, D., Maugeri, A., Weiss, M. M., Verhagen, H. J. M., IJpma, A. S., Brüggenwirth, H. T., & Majoor‐Krakauer, D. F. (2015) · Human Genetics · doi:10.1007/s00439-015-1567-0 · Cited by 43
Genetic Dissection of Marfan Syndrome and Related Connective Tissue Disorders: An Update 2012
Hoffjan, S. (2012) · Molecular Syndromology · doi:10.1159/000339441 · Cited by 44
Tarr, I. S., Hesselson, S., Iismaa, S. E., Rath, E. M., Monger, S., Troup, M., Mishra, K., Wong, C. M. Y., Hsu, P.-C., Junday, K., et al. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003527 · Cited by 43
Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease
Thakker, P., & Braverman, A. C. (2020) · Heart · doi:10.1136/heartjnl-2020-317036 · Cited by 40
Long, K. B., Li, Z., Burgwin, C. M., Choe, S. G., Martyanov, V., Sassi‐Gaha, S., Earl, J., Eutsey, R. A., Ahmed, A., Ehrlich, G. D., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.455 · Cited by 37
Angiotensin II Promotes Thoracic Aortic Dissections and Ruptures in Col3a1 Haploinsufficient Mice
Faugeroux, J., Nematalla, H., Li, W., Clément, M., Robidel, E., Frank, M., Curis, E., Ait‐Oufella, H., Caligiuri, G., Nicoletti, A., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00974 · Cited by 39
Wang, H., Liu, D., & Zhang, H. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.45963 · Cited by 34
Gaines, R., Tinkle, B. T., Halandras, P. M., Al-Nouri, O., Crisostomo, P., & Cho, J. S. (2015) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2014.10.036 · Cited by 34
Demirdas, S., van den Bersselaar, L. M., Lechner, R. L., Bos, J., Alsters, S., Baars, M. J. H., Baas, A. F., Baysal, Ö., van der Crabben, S. N., Dulfer, E., et al. (2024) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.122.003978 · Cited by 35
Müller, G. A., Hansen, U. J., Zhi, X., Griswold, B. F., Talan, M. I., McDonnell, N. B., & Briest, W. (2011) · The FASEB Journal · doi:10.1096/fj.11-182162 · Cited by 34
Heterogeneous nanomechanical properties of type I collagen in longitudinal direction
Tang, M., Li, T., Gandhi, N. S., Burrage, K., & Gu, Y. (2017) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-016-0870-6 · Cited by 29
Romero‐Ortuño, R., Kenny, R. A., & McManus, R. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110781 · Cited by 29
Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons
Islam, M., Chang, C., & Gershwin, M. E. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100077 · Cited by 29
Tae, H., Marshall, S. A., Zhang, J., Wang, M., Briest, W., & Talan, M. I. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197020 · Cited by 31
Oral phenotype and scoring of vascular Ehlers–Danlos syndrome: a case–control study
Ferré, F. C., Frank, M., Gogly, B., Golmard, L., Naveau, A., Chérifi, H., Emmerich, J., Gaultier, F., Berdal, A., Jeunemaı̂tre, X., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000705 · Cited by 32
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease
Imai, Y., Kusano, K., Aiba, T., Ako, J., Asano, Y., Harada‐Shiba, M., Kataoka, M., Kosho, T., Kubo, T., Matsumura, T., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0926 · Cited by 34
Tang, M., Li, T., Pickering, E., Gandhi, N. S., Burrage, K., & Gu, Y. (2018) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2018.07.009 · Cited by 27
Ghali, N., Baker, D., Brady, A. F., Burrows, N., Cervi, E., Cilliers, D. D., Frank, M., Germain, D. P., HULMES, D. J. S., Jacquemont, M., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0470-9 · Cited by 28
Schleit, J., Bailey, S. S., Tran, T., Chen, D. A., Stowers, S., Schwarze, U., & Byers, P. H. (2015) · Human Mutation · doi:10.1002/humu.22812 · Cited by 27
Self-citationLv, W., Lin, Y., Song, W., Sun, K., Yu, H., Zhang, Y., Zhang, C., Li, L., Suo, M., Hui, R., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0283-x · Cited by 22
Genetic aortic disease epidemiology, management principles, and disparities in care
Shalhub, S., Wallace, S. E., Okunbor, O., & Newhall, K. S. (2021) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2021.02.012 · Cited by 22
Malek, S., & Köster, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.649082 · Cited by 19
Vascular aneurysms in Ehlers‐Danlos syndrome subtypes: A systematic review
Shabani, M., Abdollahi, A., Brar, B. K., MacCarrick, G. L., Ambale‐Venkatesh, B., Lima, J. A. C., & Bodurtha, J. N. (2022) · Clinical Genetics · doi:10.1111/cge.14245 · Cited by 20
Shalhub, S., Sage, L., Demasi, J., Wallace, S. E., Fulton, D. S., Bloom, L. C., Driessnack, M., & Byers, P. H. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.06.010 · Cited by 21
Self-citationMarfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Backer, J. F. A. D., Renard, M., Campens, L., Mosquera, L. M., Paepe, A. D., Coucke, P. J., Callewaert, B. L., & Kodolitsch, Y. V. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150826093152 · Cited by 19
Barbosa, E. J. M., Pyeritz, R. E., Litt, H. I., & Desjardins, B. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34332 · Cited by 17
Endovascular Management of Vascular Complications in Ehlers–Danlos Syndrome Type IV
Alqahtani, M., Claudinot, A., Gaudry, M., Bartoli, A., Barral, P.-A., Vidal, V., Boyer, L., Busa, T., Cadour, F., Jacquier, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216344 · Cited by 16
Molecular Basis of Pathogenic Variants in the Fibrillar Collagens
Richards, A. J., & Snead, M. P. (2022) · Genes · doi:10.3390/genes13071199 · Cited by 15
Genetics of Heritable Thoracic Aortic Disease
Papatheodorou, E., Degiannis, D., & Anastasakis, A. (2022) · Cardiogenetics · doi:10.3390/cardiogenetics12010006 · Cited by 14
Legrand, A., Guery, C., Faugeroux, J., Fontaine, E., Beugnon, C., Gianfermi, A., Ferreira, I., Verpont, M., Adham, S., Mirault, T., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010059 · Cited by 13
Wang, X. J., Babameto, M., Babovic-Vuksanovic, D., Bowen, J. M., & Camilleri, M. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06265-8 · Cited by 13
“As the clinical course for patients with heterozygosity for COL3A1 null mutations appears to be less severe compared with exon-skipping or missense alterations resulting in abnormal type 3 collagen structure [11], we appraised the manifestations for those with null mutations as well as missense alterations in the pati…”
BackgroundAdham, S., Legrand, A., Bruno, R. M., Billon, C., Dalens, V., Boutouyrie, P., Mazzella, J., Guéguen, S., Frank, M., Mirault, T., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.953894 · Cited by 13
A case of vascular Ehlers-Danlos Syndrome with a cardiomyopathy and multi-system involvement
Lan, N. S. R., Fietz, M., Pachter, N., Paul, V., & Playford, D. A. (2018) · Cardiovascular Pathology · doi:10.1016/j.carpath.2018.04.006 · Cited by 12
Yamaguchi, T., Hayashi, S., Hayashi, D., Matsuyama, T., Koitabashi, N., Ogiwara, K., Noda, M., Nakada, C., Fujiki, S., Furutachi, A., et al. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62982 · Cited by 11
van den Bersselaar, L. M., van de Laar, I. M. B. H., Baars, M. J. H., Baas, A. F., Dulfer, E., den Enden, A. T. J. M. H.-V., Hilhorst‐Hofstee, Y., Kauling, R. M., Kempers, M. J. E., Oudijk, M. A., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18142 · Cited by 12
Nuche, J., Palomino-Doza, J., Arribas, F., Delgado, J. F., Ibáñez, B., Oliver, E., & Subías, P. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072509 · Cited by 12
Vascular Ehlers–Danlos Syndrome
Milewicz, D. M., Reid, A. J., & Cecchi, A. C. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000507 · Cited by 11
Stephens, S. B., Shalhub, S., Dodd, N. A., Li, J., Huang, M., Oda, S., Kancherla, K., Doan, T. T., Prakash, S. K., Weigand, J., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029518 · Cited by 11
Self-citationEvaluating perinatal and neonatal outcomes among children with vascular Ehlers–Danlos syndrome
Stephens, S. B., Russo, M. L., Shalhub, S., Beecroft, T., Weigand, J., Milewicz, D. M., & Morris, S. A. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.07.010 · Cited by 10
Genetic Risk for Aortic Aneurysm in Adolescent Idiopathic Scoliosis
Haller, G., Alvarado, D. M., Willing, M. C., Braverman, A. C., Bridwell, K. H., Kelly, M. P., Lenke, L. G., Luhmann, S. J., Gurnett, C. A., & Dobbs, M. B. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.o.00290 · Cited by 10
Nonsyndromic arteriopathy and aortopathy and vascular Ehlers–Danlos syndrome causing COL3A1 variants
Yagi, H., Takeda, N., Amiya, E., Akiyama, N., Chang, H., Ishiura, H., Sato, J., Akazawa, H., Morita, H., & Komuro, I. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62774 · Cited by 8
Wilkinson, N. R., Cervi, E., Wagner, B. E., Morris-Rosendahl, D. J., Baker, D., Flora, H. S., von Klemperer, K., Andrew, T., Ghali, N., & van Dijk, F. S. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01773-x · Cited by 8
A Novel Frameshift COL3A1 Variant in Vascular Ehlers-Danlos Syndrome
Olson, S. L., Murray, M. L., & Skeik, N. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.05.057 · Cited by 6
Shalhub, S., & Byers, P. H. (2023) · Journal of Vascular Surgery Cases and Innovative Techniques · doi:10.1016/j.jvscit.2023.101192 · Cited by 7
Self-citationToward precision medicine in vascular connective tissue disorders
Ziegler, S. G., MacCarrick, G. L., & Dietz, H. C. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62461 · Cited by 6
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease
Imai, Y., Kusano, K., Aiba, T., Ako, J., Asano, Y., Harada‐Shiba, M., Kataoka, M., Kosho, T., Kubo, T., Matsumura, T., et al. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2024.10.002 · Cited by 6
Assavarittirong, C., Au, T. Y., Nguyen, P. V., & Mostowska, A. (2021) · Cardiology in Review · doi:10.1097/crd.0000000000000419 · Cited by 6
Wang, W., Shen, H., Xie, J., Zhou, Q., Chen, Y., & Lu, H. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3255-x · Cited by 6
Liu, L., Wu, D., Tsao, P. S., Leeper, N. J., & Sayed, N. (2026) · Vascular Medicine · doi:10.1177/1358863x251394285 · Cited by 5
Genetic diagnosis of the Ehlers-Danlos syndromes
Zschocke, J., Demirdas, S., & van Dijk, F. S. (2024) · Medizinische Genetik · doi:10.1515/medgen-2024-2061 · Cited by 6
Sølyst, S., Oksjoki, R. K., Farholt, S., Nielsen, D. G., Christensen, A. H., Fagerberg, C. R., Risom, L., Gregersen, P. A., Christensen, M. B., Rasmussen, T. B., et al. (2022) · Clinical Genetics · doi:10.1111/cge.14176 · Cited by 4
Zhang, W., Han, Q., Zhou, M., Ran, F., Tong, Q. Z., Yi, L., Liu, C., & Liu, Z. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6082 · Cited by 5
Rahman, Q., Naidu, S., Chong, B. W., & Stone, W. M. (2019) · Vascular and Endovascular Surgery · doi:10.1177/1538574418824185 · Cited by 5
Genetics of the Ehlers–Danlos syndrome: More than collagen disorders
Van Damme, T., Syx, D., Coucke, P., Symoens, S., De Paepe, A., & Malfait, F. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1022528 · Cited by 4
Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
Watanabe, A., Naing, B. T., Tanigaki, S., Ono, M., Iwashita, M., & Shimada, T. (2014) · International Medical Case Reports Journal · doi:10.2147/imcrj.s59879 · Cited by 4
Geenen, R., & Lumley (2018) · Utrecht University Repository (Utrecht University) · doi:10.3233/978-1-61499-878-5-i
Genetic Disorders of the Vasculature
Brownstein, A. J., Ziganshin, B. A., & Elefteriades, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99692-3 · Cited by 4
Ehlers‐Danlos syndrome, vascular type: A novel missense mutation in the COL3A1 gene
Masuno, M., Watanabe, A., Naing, B. T., Shimada, T., Fujimoto, W., Ninomiya, S., Ueda, Y., Kadota, K., Kotaka, T., Kondo, E., et al. (2012) · Congenital Anomalies · doi:10.1111/j.1741-4520.2011.00353.x · Cited by 3
Shalhub, S. (2025) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.04.028 · Cited by 4
Prevalence and outcomes of select rare vascular conditions in females: A descriptive review
Sorber, R. A., Bowen, C. J., Radomski, S. N., & Shalhub, S. (2023) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2023.10.003 · Cited by 3
Miolo, G., Machin, P., Conto, M. D., Fortuna, S., Viglio, S., Puppa, L. D., Geremia, S., & Corona, G. (2025) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70095 · Cited by 3
Maraj, B., Harding-Theobald, E. R., & Karaki, F. M. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4445-3 · Cited by 3
Cell and tissue markers of atherosclerosis
Kashirskikh, D. A., Khotina, V. A., Sukhorukov, V. N., Sobenin, I. A., & Orekhov, A. N. (2020) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2020-9-2-102-113 · Cited by 3
A contemporary review of the diagnosis and management of vascular Ehlers–Danlos syndrome
Chen, A., Stacey, C., & Coughlin, P. A. (2023) · Journal of Vascular Societies Great Britain and Ireland · doi:10.54522/jvsgbi.2023.064 · Cited by 3
Low‐Allele‐Frequency Somatic Variants in a Cohort of Sporadic Saccular “Berry” Cerebral Aneurysms
Karasozen, Y., McAvoy, M., Parada, C. A., Busald, T., Kondaboina, S., Osbun, J., Ruzevick, J., Levitt, M., Gonzalez-Cuyar, L. F., Kim, L. J., et al. (2025) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.123.032483 · Cited by 2
Genetic Considerations in Patients with Aortic Disease
Shalhub, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-15192-2_3 · Cited by 2
Intraperitoneal bladder rupture in a young child with vascular Ehlers‐Danlos syndrome
Nanduri, R., Jones, E., Miller‐Hance, W. C., Lewis, A. M., & Morris, S. A. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62004 · Cited by 2
Villaman, C. M. G., Quiñónez, R. D., & Espinal, L. C. (2024) · BMJ Case Reports · doi:10.1136/bcr-2024-260764 · Cited by 2
Map2k6 is a potent genetic modifier of arterial rupture in vascular Ehlers-Danlos syndrome mice
Bowen, C. J., Sorber, R. A., Calderón, J. F., Doyle, J. J., Rykiel, G., Burger, Z., Zhang, X., Camejo, W. A. E., Anderson, N. K., Sabnis, S., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.187315 · Cited by 3
An Unusual Cause of Peroneal Neuropathy
Ananth, A., Yang, Y., Lalani, S. R., & Lotze, T. B. (2014) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2014.04.006 · Cited by 2
Brugada Syndrome in a Patient with Vascular Ehlers-Danlos Syndrome: Sudden Death Risk Amplified
D’Souza, J., Malhotra, D., Goud, A., Dahagam, C., & Everett, G. D. (2017) · Cureus · doi:10.7759/cureus.1178 · Cited by 2
Metadata
- Authors
- Leistritz, D. F., Pepin, M. G., Schwarze, U., & Byers, P. H.
- Affiliations
- University of Washington (US)
- Corresponding author
- Byers, Peter H.
- ORCID
- Byers, Peter H.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 13
- Issue
- 8
- Pages
- 717-722
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2076783554
- Cited by
- 141
- References
- 10
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 8 · 2023: 4 · 2022: 13 · 2021: 8 · 2020: 7 · 2019: 13 · 2018: 8 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 15 · 2013: 6 · 2012: 6
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- Ehlers-Danlos syndrome type IV, COL3A1, haploinsufficiency, null mutations, premature stop codon, nonsense-mediated mRNA decay, penetrance, life expectancy, vascular complications, family history (medicine)
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aneurysm, Child, Child, Preschool, Ehlers-Danlos Syndrome, Female, Humans, Life Expectancy, Male, Middle Aged, Mutation, Sequence Analysis, DNA, Penetrance, Collagen Type III, Kaplan-Meier Estimate, Young Adult, Genetic Association Studies, Haploinsufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review